Quest Diagnostics, Inc.

DGX

$143.72

+22.2% (1 year change)

Market Cap

$17.4 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$112.33 - $159.87

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

7.78x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$2.41 (1.69%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $17.4 Billion
Enterprise Value $20.8 Billion
Dividend Yield $2.41 (1.69%)
1 Year Return +23.9%
52-Week High $159.87
52-Week Low $112.33
Beta 0.23
Outstanding Shares 122 Million
Avg 30 Day Volume 1.36 Million

Valuation

P/E Ratio 7.78
PEG 3.25
Earnings per Share $16.73
Price to Sales Ratio 1.6
Price to Book Ratio 2.99
Revenue to Enterprise Value 1.89
EBIT to Enterprise Value 7.47
Total Debt to Enterprise Value 0.19
Debt to Equity 0.68

Profitability

Revenue $11.1 Billion
Gross Profit $4.55 Billion
EBIT $2.79 Billion
Net Income $2.24 Billion
Profit Margin 20.23%
Quarterly Earnings Growth (YoY) +239.5%
Return on Equity 37.92%
Return on Assets 17.39%
Return on Invested Capital 24.67%

Insider trades

No purchases

6,375 shares sold (2 transactions)

No purchases

8,536 shares sold (1 transactions)

No purchases

139,751 shares sold (1 transactions)

No purchases

No sells

Q1 2021 Q2 2021 Q3 2021 Q4 2021

About Quest Diagnostics, Inc.

CEO: Stephen Rusckowski

Employees: 47,000

Industry: Dental Laboratories

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.

Similar stocks

Laboratory Corp. Of America Holdings
Psychemedics Corp.
Neogenomics Inc.
Enzo Biochem, Inc.
Translate Bio Inc
Qiagen NV

News

DGX December 17th Options Begin Trading

DGX December 17th Options Begin Trading

Investors in Quest Diagnostics, Inc. (Symbol: DGX) saw new options begin trading today, for the December 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the...

iShook Finance iShook Finance, 6 days ago
Quest Diagnostics Completes Transition to Regional Lab in Clifton, New Jersey

Quest Diagnostics Completes Transition to Regional Lab in Clifton, New Jersey

Large Next-Generation Facility To Serve Seven States

CoStar CoStar, 7 days ago
Quest Diagnostics subsidiary suffers data security incident

Quest Diagnostics subsidiary suffers data security incident

No summary available.

Seeking Alpha Seeking Alpha, 12 days ago